Corporate & Investment Diligence


The value of intangible assets

Understanding the value of a company‚Äôs intellectual property (IP) assets can influence prices in M&A, financing, and licensing transactions. We take a broad view of intangible assets and analyze all of your company’s IP, including patents, patent applications, licensing agreements, know-how, and trademarks, to assess your overall IP strengths and liabilities.

From both sides of the deal

We conduct due diligence reviews of IP for acquiring and merging companies as well as for institutional investors and venture capitalists. We also assist our clients in diligence by these groups. Through working with corporate clients, including Fortune 500 companies and other global leaders with track records of success, we are intimately familiar with the business realities of IP. Our work with investors also keeps us current on what the market looks for in evaluating IP assets. Because we have deep experience working on both sides of deals, you benefit from a comprehensive view of the diligence process.

Science and technology expertise

Our IP analysis includes landscape review and competitive intelligence, and technology clients rely on us to assess IP portfolios for acquisition, investment, licensing, or public offering. Our expertise covers a broad spectrum of technical areas, including:

  • Antibodies
  • Biomarkers
  • Biomaterials
  • Cardiovascular devices
  • Cell-based therapies
  • Ceramics
  • Chemical and biological reactors
  • Chemical processes
  • Coatings
  • Consumer products
  • Cosmetics
  • Dental devices
  • Devices for improving urogenital and gastrointestinal health
  • Diagnostic devices
  • Diagnostics
  • Dialysis components
  • Drug delivery devices
  • Drug delivery systems
  • Drug formulations
  • Drug-device combination products
  • Drug-eluting stents
  • EEG headsets
  • Electronics and semiconductor materials
  • Environmental monitoring
  • Food and beverage equipment
  • Food processing
  • Gene therapy
  • Genetically-modified animals
  • Genomics
  • Green/clean energy technology
  • Imaging
  • Immunotherapies
  • Industrial automation and materials processing
  • Industrial hygiene
  • Laboratory equipment
  • Manufacturing & control systems
  • Manufacturing & packaging
  • Medical device coatings
  • Metabolomics
  • Microbiology
  • Microbiome therapies
  • Microfluidic devices
  • Microfluidics
  • Multiplex assays
  • Nanotechnology
  • Next generation sequencing
  • NMR devices
  • Nucleic acids
  • Nutraceuticals
  • Orthopedic devices
  • Peptides
  • Pharmaceuticals
  • Plant and agricultural technology
  • Plastics and polymer science
  • Proteomics
  • Repurposed drugs
  • Sequencing equipment
  • Stem cell technology
  • Therapeutic methods
  • Ultrasound and thermoacoustic imaging